Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma (NCT04956367) | Clinical Trial Compass
CompletedPhase 3
Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma
Philippines16 participantsStarted 2019-07-01
Plain-language summary
This study determined the efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser with placebo in the treatment of striae gravidarum of postpartum Filipino women.
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Postpartum patients with ages 18 to 45 years
* Fitzpatrick skin type III-V
* having bilateral symmetrical SG of red, white or a combination of both types.
Exclusion Criteria:
* pregnancy
* breastfeeding
* heavy consumption of alcoholic beverages
* dermatological conditions such as psoriasis, systemic lupus erythematosus and atopic dermatitis
* uncontrolled hypertension, diabetes mellitus, heart disease, acute and chronic liver/kidney impairment/disease;
* elevated liver function tests (SGPT, SGOT), and serum creatinine;
* intake of any medications that may influence the outcome of the study;
* intake of any vitamins/minerals or any supplements in the past 6 months; and
* application of any topical agents (e.g., whitening, anti-aging) in the past 6 months